Cell Signaling Technology

PathScan® Phospho-4E-BP1 (Thr37/Thr46) Sandwich ELISA Antibody Pair

#7854 · elisa · $553

64

Evidence Score · Well-Established

Used by 188 independent labs across 202 papers. How we score this →

100

Citing papers

9k

Combined citations

Supplier page Find this product

Research areas

MicroRNA in disease regulation27 Cancer-related molecular mechanisms research19 Cancer Cells and Metastasis13 Circular RNAs in diseases11 RNA modifications and cancer10 Macrophage Migration Inhibitory Factor7 Lung Cancer Treatments and Mutations6 Alzheimer's disease research and treatments6

Papers citing this product

1

Epithelial to Mesenchymal Transition Is Mechanistically Linked with Stem Cell Signatures in Prostate Cancer Cells

PLoS ONE·2010·406 cit.·DOI

2

β-Amyloid Monomers Are Neuroprotective

Journal of Neuroscience·2009·406 cit.·DOI

3

AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells

Nature Communications·2019·360 cit.·DOI

4

miR-200 Regulates PDGF-D-Mediated Epithelial–Mesenchymal Transition, Adhesion, and Invasion of Prostate Cancer Cells

Stem Cells·2009·314 cit.·DOI

5

An Ovol2-Zeb1 Mutual Inhibitory Circuit Governs Bidirectional and Multi-step Transition between Epithelial and Mesenchymal States

PLoS Computational Biology·2015·300 cit.·DOI

6

LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathway

Oncotarget·2016·265 cit.·DOI

7

The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200–dependent pathway in mice

Journal of Clinical Investigation·2011·197 cit.·DOI

8

The major human and mouse granzymes are structurally and functionally divergent

The Journal of Cell Biology·2006·195 cit.·DOI

9

ZEB1, ZEB2, and the miR-200 family form a counterregulatory network to regulate CD8+ T cell fates

The Journal of Experimental Medicine·2018·173 cit.·DOI

10

RETRACTED: Cancer-Associated Fibroblasts-Derived Exosomes Suppress Immune Cell Function in Breast Cancer via the miR-92/PD-L1 Pathway

Frontiers in Immunology·2020·172 cit.·DOI

Similar products

Product	Vendor	Evidence	Price	Papers
PathScan® Phospho-4E-BP1 (Thr37/Thr46) Sandwich ELISA Kit	Cell Signaling Technology	64	$66,129,740	100

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.